Evidence map›Paper›PMID 42256030›Full record

ArticleThe journal of allergy and clinical immunology. Global2026

Knowledge among primary care physicians on urticaria treatment: Impact of educational interventions.

Jorge Sánchez, Ana Caraballo, Jaime Ocampo, Elizabeth García

Abstract read
In one paragraph

Article in The journal of allergy and clinical immunology. Global, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jorge SánchezGroup of Clinical and Experimental Allergy (GACE), "Alma Mater de Antioquia" Hospital, University of Antioquia, Medellín, Colombia.
Ana CaraballoGroup of Clinical and Experimental Allergy (GACE), "Alma Mater de Antioquia" Hospital, University of Antioquia, Medellín, Colombia.
Jaime OcampoAllergy Section, Pediatrics Department, "Fundación Santa Fe de Bogotá." Medical School, Universidad de los Andes, Unidad Médico Quirúrgica de Otorrinolaringología (UNIMEQ-ORL), Bogotá, Colombia.
Elizabeth GarcíaAllergy Section, Pediatrics Department, "Fundación Santa Fe de Bogotá." Medical School, Universidad de los Andes, Unidad Médico Quirúrgica de Otorrinolaringología (UNIMEQ-ORL), Bogotá, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Primary care physicians (general practitioners, family physicians, emergency physicians, among others) are often the first point of medical contact for patients with urticaria. Appropriate initial management enables early disease control and reduces the overall burden on patients and health care systems. Objective: We evaluated changes over time in primary care physicians' (PCPs) knowledge regarding diagnosis and management of urticaria. Additionally, we explored the characterization of access barriers reported by urticaria specialists. Methods: We used a multimodal approach to assess changes in knowledge across two periods (2022 and 2025). Three sources of information were analyzed: (1) a knowledge test using a standardized questionnaire, (2) review of medical records from 3 health care centers, and (3) analysis of the Colombian national medical prescription registration system, SISPRO. Diagnostic and treatment domains were evaluated across all information sources. Results: We observed that the level of knowledge of guidelines among PCPs has increased in the different clinical domains (diagnosis, therapy). However, more than 50% of PCPs still have gaps in their understanding of the correct management practices. Several barriers were identified among PCPs but also among specialists (allergists, dermatologists), generally related to the administrative process. Conclusion: Educational initiatives appear to positively influence PCPs' knowledge and management of urticaria; however, persistent gaps highlight the need for ongoing, targeted educational strategies and system-level improvements to reduce barriers in medical care.

Indexed as

Angioedemaantihistaminesdiagnosisdupilumabeducationomalizumabremibrutinibtherapyurticaria

Identifiers

PMID42256030
PMCPMC13235463

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.